Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Calvo-Aranda <i>et al</i>.

Ramiro, Sofia; Mostard, Rémy; Landewé, Robert Bm

Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Calvo-Aranda et al.

Ramiro, Sofia; Mostard, Rémy; Landewé, Robert Bm.

Ramiro S; Rheumatology, Zuyderland Medical Center, Heerlen, Limbug, The Netherlands sofiaramiro@gmail.com.
Mostard R; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Landewé RB; Department of Pulmonology, Zuyderland Medical Center, Heerlen, The Netherlands.

Ann Rheum Dis ; 2020 Dec 14.

Article in English | MEDLINE | ID: covidwho-2277666

Keywords

epidemiology; glucocorticoids; interleukin 1 receptor antagonist protein

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Language: English Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-219534

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google